Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Search by expertise, name or affiliation
New insights into anti-HER-2 receptor monoclonal antibody research
R. Kumar, M. Mandal,
R. Vadlamudi
Research output
:
Contribution to journal
›
Article
›
peer-review
32
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New insights into anti-HER-2 receptor monoclonal antibody research'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Cell
100%
Breast Cancer
83%
Monoclonal Antibody
66%
Trastuzumab
66%
Receptor
50%
Growth Factor
50%
Epidermal Growth Factor Receptor 2
50%
Neu Differentiation Factor
33%
Protein Tyrosine Kinase
16%
Metastatic Carcinoma
16%
Cell Surface
16%
down Regulation
16%
Ligand
16%
In Vitro
16%
Phenotype
16%
Cell Proliferation
16%
Lung Cancer
16%
Prostate Cancer
16%
Breast Tumor
16%
Cervical Cancer
16%
Ovarian Cancer
16%
Receptor Expression
16%
Mitogen-Activated Protein Kinase
16%
Therapy Effect
16%
Colon Cancer
16%
Phosphoinositide 3-Kinase
16%
Transcription Factor
16%
Adenoviridae
16%
Development
16%
Proto Oncogene
16%
Introspection
16%
Antisense
16%
Growth Stimulation
16%
Ribozyme
16%
Growth
16%
Cells
16%
Cancer
16%
Growth Factor Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
83%
Monoclonal Antibody
66%
Trastuzumab
66%
Receptor
50%
Epidermal Growth Factor Receptor 2
50%
Neu Differentiation Factor
33%
Clinical Trial
33%
Protein Tyrosine Kinase
16%
Metastasis
16%
Ligand
16%
Mitogen Activated Protein Kinase
16%
Colon Cancer
16%
Uterine Cervix Cancer
16%
Breast Tumor
16%
Phosphatidylinositol 3 Kinase
16%
Lung Cancer
16%
Prostate Cancer
16%
Transcription Factor
16%
Ovary Cancer
16%
Growth Factor Receptor
16%
Adenoviridae
16%
Oligonucleotide
16%
Ribozyme
16%